SCHEMBL29636671

SCHEMBL29636671

NCCC(N)c1cc(-c2ccco2)nc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.52
POLB P06746 9/20 0.52
ALDH1A1 P00352 7/20 0.52
TDP1 Q9NUW8 7/20 0.52
L3MBTL1 Q9Y468 7/20 0.52
GLA P06280 4/20 0.52
HPGD P15428 4/20 0.52
GAA P10253 3/20 0.52
ESR1 P03372 1/20 0.52
TP53 P04637 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
RECQL P46063 6/20 0.48
MAPT P10636 6/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
ADORA2A P29274 2/20 0.45
ADORA2B P29275 1/20 0.45
ADORA1 P30542 1/20 0.45
CTDSP1 Q9GZU7 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28967175 1.00 KDM4E (0.52) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL23234949 0.75 KDM4E (0.62) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL27795966 0.74 KDM4E (0.61) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL28967193 0.72 ALDH1A1 (0.59) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL23015082 0.72 ACP1 (0.68) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL29636675 0.72 ACP1 (0.68) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL12203776 0.72 KDM4E (0.62) KDM4EPOLBALDH1A1TDP1L3MBTL1
SCHEMBL23015098 0.72 ELANE (0.42) KDM4EALDH1A1TDP1L3MBTL1MAPK1
SCHEMBL29636665 0.72 ELANE (0.42) KDM4EALDH1A1TDP1L3MBTL1MAPK1
Hydrochloric Acid SCHEMBL29636779 0.72 ALDH1A1 (0.57) KDM4EALDH1A1HPGDMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP claimed